On the public citation graph

SCD and MTHFD2 inhibitors for high‐risk acute myeloid leukaemia patients, as suggested by ELN2017‐pathway association

0 signed · 15 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/0145-2126(91)90189-zopenalex-snapshot
Basis for natural resistance to methotrexate in human acute non-lymphocytic leukemia
inferredcites →https://doi.org/10.1038/s41375-020-0806-0openalex-snapshot
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia
inferredcites →https://doi.org/10.1038/s41568-019-0230-9openalex-snapshot
The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML
inferredcites →https://doi.org/10.1038/s41586-018-0623-zopenalex-snapshot
Functional genomic landscape of acute myeloid leukaemia
inferredcites →https://doi.org/10.1038/s43018-022-00331-yopenalex-snapshot
Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress
inferredcites →https://doi.org/10.1056/nejmoa1301689openalex-snapshot
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1084/jem.20151574openalex-snapshot
Targeting MTHFD2 in acute myeloid leukemia
inferredcites →https://doi.org/10.1182/blood-2016-08-733196openalex-snapshot
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
inferredcites →https://doi.org/10.1182/blood.2022016033openalex-snapshot
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
inferredcites →https://doi.org/10.3389/fonc.2022.896426openalex-snapshot
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4786277openalex-extracted
Selective Elimination of Genetic Variants of Human Embryonic Stem Cells from High Vulnerability to Ferroptosis
inferred← citeshttps://doi.org/10.1002/jcp.70000openalex-snapshot
Reprogramming of Fatty Acid Metabolism in Acute Leukemia
inferred← citeshttps://doi.org/10.1016/j.gendis.2026.102118openalex-snapshot
Molecular insights into fatty acid metabolism reprogramming: Targeting metabolic vulnerabilities in hematological malignancies
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c00023openalex-snapshot
Discovery of 1,2,3,4-Tetrahydrochromeno[3,4- c ]pyridin-5-one Derivatives as Novel MTHFD Inhibitors for the Treatment of Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.1038/s41375-024-02390-9openalex-snapshot
Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.